Trial intelligence / Profile preview

DDAVP plus factor VIII concentrate combination treatment in non-severe hemophilia A

NL-OMON47474Completed

Sponsor
Erasmus MC
Start
Feb 2017
Modality
Small Molecules, Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label, single-arm trial of desmopressin and Factor VIII in hemophilia A, sponsored by Erasmus MC. Started Feb 2017; status: completed.

02

Drugs

desmopressinFactor VIII
03

Conditions

hemophilia A

Beyond the preview

Go deeper on NL-OMON47474.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON47474.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call